Future Oncology, Volume 20, Issue 13 (2024)

Browse this journal
Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 20, Issue 13 (2024)

See all volumes and issues
Volume 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Plain Language Summary of Publication

Plain Language Summary of Publication
A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial
Mansoor R Mirza, Antonio González-Martín, Whitney S Graybill, David M O’Malley, Lydia Gaba, Oi Wah Stephanie Yap, Eva M Guerra, Peter G Rose, Jean-François Baurain, Sharad A Ghamande, Hannelore Denys, Emily Prendergast, Carmela Pisano, Philippe Follana, Klaus Baumann, Paula M Calvert, Jacob Korach, Yong Li, Izabela A Malinowska, Divya Gupta & Bradley J Monk
Pages: 799-809
Published online: 22 Jan 2024
AbstractforA plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial | Full Text | PDF (1.9 MB)
  • 983 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Clinical Trial Protocol

Review Article
CaboCombo: a prospective, phase IV study of first-line cabozantinib + nivolumab for advanced renal cell carcinoma
Philippe Barthélémy, Pascale Dutailly, Bryan Qvick, Valerie Perrot & Elena Verzoni
Pages: 811-819
Published online: 08 Apr 2024
First Page PreviewforCaboCombo: a prospective, phase IV study of first-line cabozantinib + nivolumab for advanced renal cell carcinoma | Full Text | References | PDF (1.9 MB) | EPUB
  • 1560 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Short Communication

Brief Report
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union
Lucjan Wyrwicz, César A Rodríguez Sánchez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer & Tevy San
Pages: 821-832
Published online: 02 Feb 2024
AbstractforReal-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 966 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Brief Report
Treatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan
Hitomi Sanno, Kazuko Taniguchi, Yuya Yoshimoto & Shigehira Saji
Pages: 833-849
Published online: 02 Feb 2024
AbstractforTreatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan | Full Text | References | PDF (10.2 MB) | EPUB | Supplemental
  • 938 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Brief Report
Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer
Keith A Betts, Sophie Gao, Saurabh Ray & Adam J Schoenfeld
Pages: 851-862
Published online: 19 Jan 2024
AbstractforReal-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1644 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-Analysis

Clinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis
Mayur M Amonkar, Lauren A Abderhalden, Grace E Fox, Andrew M Frederickson, Torkia Grira, Alexander Gozman, Usha Malhotra, William Malbecq & Katherine G Akers
Pages: 863-876
Published online: 14 Feb 2024
First Page PreviewforClinical outcomes for previously treated patients with advanced biliary tract cancer: a meta-analysis | Full Text | References | PDF (2.6 MB) | EPUB | Supplemental
  • 990 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer: a plain language summary of the DESTINY-Lung01 study
Egbert F. Smit
Plain Language Summary of Publication | Published online: 16 Jul 2024
Open Access
Prevalence of homologous recombination biomarkers in multiple tumor types: an observational study
Cai Chen et al.
Rapid Communication | Published online: 16 Jul 2024
Cost of early progression: patients with epidermal growth factor receptor mutated metastatic non-small-cell lung cancer
Princic Nicole et al.
Rapid Communication | Published online: 16 Jul 2024
Open Access
Co-expression of CD44v6 and MMP2 predicts lung metastasis and unfavorable prognosis in osteosarcoma
Shoulei Liang et al.
Rapid Communication | Published online: 16 Jul 2024
View all latest articles